Siblings 圖書 [1/1] 期刊論文 [327/330] Collection Statistics 近3年內發表的文件:16(8.94%) 含全文筆數:115(64.25%) 文件下載次數統計 下載大於0次:115(100.00%) 下載大於100次:112(97.39%) 檔案下載總次數:39303(22.07%) 最後更新時間: 2024-12-01 07:53 Top Upload Loading... Top Download Loading... Recent Submissions Single-cell RNA sequencing via Endo... Nivolumab plus ipilimumab (N plus I... Risk of type 2 diabetes mellitus an... Phase 1 studies of D07001-F4 and D0... Updated overall survival (OS) from ... Outcomes of post-immunotherapy dura... Updated overall survival (OS) from ... Updated results of the FOENIX-CCA2 ... Comparative genomic analysis and it... A phase II trial of nivolumab, gemc...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 151-175 of 179. (8 Page(s) Totally) << < 1 2 3 4 5 6 7 8 > >> View [10|25|50] records per page

Date	Title	Relation
2009-12	A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma	Cancer Chemotherapy and Pharmacology. 2009 Dec;65(1):151-157.
2009-10	Pharmacoeconomic analysis of capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX) in the first line treatment of metastasis colorectal cancer in Taiwan	Value in Health. 2009 Oct;12(7):A278.
2009-09	Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors	EJC Supplements. 2009 Sep;7(3):16.
2009-05-20	Differential response of primary or secondary exon 13/14 and exon 17 c-kit mutant to nilotinib and sunitinib: Findings from a cell-based drug-screening platform	Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15636.
2009-05-20	A phase II study of gemcitabine-based chemoradiotherapy (CCRT) after triplet induction chemotherapy (ICT) for locally advanced pancreatic cancer (LAPC): A Taiwan Cooperative Oncology Group (TCOG) study	Journal of Clinical Oncology. 2009 May 20;27(15):Abstract number e15562.
2009-05-20	Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide-the molecular mechanism and the clinical application	Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number e19512.
2009-05-20	Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587.
2009-05	RAD001 (everolimus) suppresses growth of a gastric MALT lymphoma cell Line via downregulation of pAKT/mTOR and BAFF/NF-\#954;B signal transduction pathways	Cancer Research. 2009 May;69:Abstract number 2762.
2009	Adjuvant interferon therpay after curative therapy for hepatocellular carcinoma (HCC): A meta-analysis	Annals of Oncology. 2009;20(Suppl. 7):91.
2008-05	Cost-minimization analysis of capecitabine for advanced gastric cancer in Taiwan	Value in Health. 2008 May-Jun;11(3):A64-A65.
2008-05	Pharmacoeconomic analysis of capecitabine for advanced gastric cancer in Taiwan	Journal of Clinical Oncology. 2008 May;26(15):Abstract number 15576.
2008-05	Phase I/II study of capecitabine and PHY906 in hepatocellular carcinoma	Journal of Clinical Oncology. 2008 May;26(15 Suppl):Abstract number 4610.
2008	Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment	Journal of Hepatology. 2008;48(Suppl. 2):S145-S146.
2007-09	A phase II trial of oxaliplatin with high-dose of 5-fluorouracil and leucovorin in the first-line treatment of inoperable, locally advanced or metastatic biliary tract cancer	EJC Supplements. 2007 Sep;5(4):268.
2007-06	H pylori-positive gastric diffuse large B-cell lymphomas are potentially curable by H pylori eradication therapy	Journal of Clinical Oncology. 2007 Jun;25(18, Suppl.):Meeting Abstract 8093.
2007-05	Pharmacoeconomic analysis of capecitabine in adjuvant treatment of stage III colon cancer in Taiwan	Value in Health. 2007 May-Jun;10(3):A11-A12.
2006-11	Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity	EJC Supplements. 2006 Nov;4(12):59.
2005-06	An open, multi-center, phase II clinical trial to evaluate efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer preliminary report	Journal of Clinical Oncology. 2005 Jun;23(16):Abstract number 346S.
2004-08-02	Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer	British Journal of Cancer. 2004 Aug;91(3):453-458.
2004-08	Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma	Haematologica. 2004 Aug;89(8):1015-1017.
2004-07	Comparison of the antitumor activity of thalidomide between hepatitis B (HBV)and hepatitis C (HCV)-related hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2004 Jul;22(14):Abstract number 362S.
2004-06	Acute hemorrhagic rectal ulcer syndrome: A new clinical entity? Report of 19 cases and review of the literature	Diseases of the Colon and Rectum. 2004 Jun;47(6):895-903.
2003-11	Use of power Doppler sonography and circulating angiogenic factors to assess the potential antiangiogenic effect of thalidomide in hepatocellular carcinoma	Cancer Epidemiology Biomarkers & Prevention. 2003 Nov;12(11):1288S.
2002-11	Expression of nuclear BCL10 is highly correlated with the expression of nuclear NF-kB and is predictive of Helicobacter pylori-dependent status in early-stage high-grade gastric MALT lymphoma	European Journal of Cancer. 2002 Nov;38(Suppl. 7):S162.
2002	Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma	International Journal of Cancer. 2002;Suppl. 13:336-337.

Showing items 151-175 of 179. (8 Page(s) Totally) << < 1 2 3 4 5 6 7 8 > >> View [10|25|50] records per page